ClinicalTrials.Veeva

Menu

Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Completed

Conditions

Endoplasmic Reticulum Stress
Recurrent Pregnancy Loss

Treatments

Other: x box binding protein

Study type

Observational

Funder types

Other

Identifiers

NCT04455256
tgk-xbp

Details and patient eligibility

About

To evaluate endoplasmic reticulum stress in women with recurrent pregnancy loss and those who had healthy births in the same age group. The level of the unfolded protein X box binding protein 1 (XBP-1) is measured. It is aimed to show the effect of endoplasmic reticulum stress on recurrent pregnancy loss.

Enrollment

90 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • with three or more miscarriages before 20 th week of gestation
  • had no chronic or acute inflammatory disease
  • used no steroids, anti-inflammatory, or antioxidant medications

Exclusion criteria

  • had inflammatory diseases
  • had systemic disease
  • Anatomical abnormalities, infectious, endocrine, or genetic etiologies

Trial design

90 participants in 2 patient groups

recurrent pregnancy loss group
Description:
Women between the ages of 18 and 45 who had a history of miscarriage under 3 weeks and above 22 weeks were included in this group.
Treatment:
Other: x box binding protein
women who had healthy birth
Description:
Women between the ages of 18-45 who have not had a history of pregnancy loss and who have had at least one healthy birth and no known chronic diseases are included in this group.
Treatment:
Other: x box binding protein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems